Location: Home
  • search
  • go
  • Relate News
  • 11/30/2018MacroGenics and Zai Lab Announce License Agreement of Three I/O Drugs ...
  • 11/29/2018Online Healthcare Platform Jianke.com to Form Alliance with Pfizer
  • 11/29/2018Chi-Med Signs Agreements To Test Two New Drug Candidates
  • 11/29/2018IQVIA: The Chinese Pharmaceutical Market to Grow at 5.5% CAGR by 2022
  • 11/29/2018WuXi Biologics and ABL Enter Development and Clinical Manufacturing Pa...
  • 11/29/2018Who Are the Investors Supporting He Jiankui, the Chinese Scientist beh...
  • 11/29/2018Immunitor to Initiate Clinical Development of Oral TB Vaccine in China
  • 11/29/2018Datwyler to Enter China to Meet Needs for Injectable Drug Components
  • 11/29/2018TRACON Pharma and I-Mab Biopharma Announce Partnerships for Multiple I...
  • 11/29/2018WuXi AppTec Launches $1B+ IPO in Hong Kong
  • 11/28/2018Revenues Up and Profits Down for Chinese Pharma in First Ten Months of...
  • 11/28/2018Zymeworks and BeiGene Announce License Agreement for HER2-Targeted Can...
  • 11/27/2018WuXi Biologics Begins Construction of A Major Biologics Center in Shan...
  • 11/27/2018WSJ: Drugmakers Gain More Access to China, But at a Price
  • 11/27/2018China Approved 30 New Drugs from Foreign Countries in the Past 21 Mont...
  • 11/27/2018Hikma Pharma to Sell Hansoh Pharma's Injectable Anticancers in the U.S...
  • 11/26/2018Gene-Edited Babies: China Wants To Be The World Leader, But At What Co...
  • 11/26/2018NHC and SATCM Issue New Pharmacy Service Policy, Banning Contract Mana...
  • 11/26/2018CPA: Review of Chinese Hospital Drug Market Changes in the Past Five Y...
  • 11/26/2018Chi-Med and Eli Lilly Announce First Commercial Launch of Fruquintinib...
  • 11/23/2018Recent Executive Moves
  • 11/23/2018MOFCOM Solicits Comments on Draft Guidelines for National Classificati...
  • 11/23/2018National Pharmacopoeia Commission Solicits Comments on Guide for Gener...
  • 11/22/2018Trump Administration Accuses China of Unfairly Using Venture Capital t...
  • 11/20/2018Sanofi China to Open New $114M Research Site in Suzhou
  • 11/20/2018Alphamab raises $100M in Series A financing from US, Asian investors
  • 11/19/2018Huadong Medicine Completes Acquisition of U.K.'s Sinclair Pharma
  • 11/16/2018Chi-Med Announces Negative Results of Phase III Chinese Trial for Fruq...
  • 11/16/2018NMPA Grants Priority Review to BeiGene's NDAs for Zanubrutinib and Tis...
  • 11/15/2018MorphoSys and I-Mab Enter Strategic Alliance for MorphoSys's Novel I/O...
  • Page:128/334 Total number of articles:9998: [First][<<] [126] [127] [128] [129] [130] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group